What's breaking now, across thousands of outlets.
The final rule retains most of the core objectives from the December 2025 proposal, but ONC significantly scaled back its approach, stopping short of the sweeping overhaul of the health IT certification program it initially proposed.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
The Kano State Centre for Disease Control has conducted a simulation exercise for health workers to test the state’s preparedness for a possible Ebola outb Read More…
A new study links cannabis use to loud snoring and breathing pauses during sleep, with stronger associations among frequent users.
Key PointsiShares U.S. Pharmaceuticals ETF provides highly concentrated domestic exposure, while VanEck Pharmaceutical ETF offers a more global portfolio.
New research challenges a leading explanation for the decline in overdose deaths in the United States.
The companies said the findings suggest the treatment has a “limited” impact in HER2-low breast cancer, an area where AstraZeneca and Daiichi Sankyo’s Enhertu has already set a high bar.
Roche will seek European approval for its promising new breast cancer pill giredestrant later than it once expected, highlighting how US drug pricing pressure may be affecting pharmaceutical…
